Stock overview
Avalo Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
AVALO THERAPEUTICS INC (AVTX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $15.08
- · AVTX
- Tracked holders
- 2 funds
- Latest available 13F per fund
AVTX · USD
Price
$15.08
-$4.51
(-23.02%)
over selected range
Close · Sep 28, 2026
Market closed
21 stored daily closes
$15.08
Sep 28, 2026
- Range low
- $15.08
- Range high
- $19.71
- Observations
- 21
- Session date
- Sep 28, 2026
Aug 28, 2026–Sep 28, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $10,164,000 | 0.05% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | +197% 26'Q2 | $6,601,056 | 0.01% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market